Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Natural Products Journal, The
  4. Volume 15, Issue 2
  5. Article
Volume 15, Issue 2
  • ISSN: 2210-3155
  • E-ISSN: 2210-3163

Abstract

The medicinal properties of the genus are evident and many studies indicate its usefulness to treat many diseases. However, the production of -based products has been hampered by its criminalization. Currently its cultivation is not allowed in Brazil, except in specific situations. It increases the price of -based products, as it requires the importation of inputs, making it difficult for most of the population to access such medicines. In this context, this review presents an overview of Brazilian legislation on medical and the current market for products in Brazil. The main goal is to encourage the cultivation of medical and the distribution of its products by the Brazilian Unified Health System. In addition, it presents recommendations to implement cultivation based on a bibliographic survey carried out in scientific databases and clinical evidence of the effectiveness of in treating patients suffering from several diseases and conditions, although more complete studies are needed to confirm both risk-benefit relationship and dose to be administered. After searching for legislation and bills on government websites, it became evident that there was a need for changes in Brazilian legislation to enable cultivation in Brazil. However, there are several proposals for legislation in progress, and Brazil can significantly benefit from this therapeutic option.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/npj/10.2174/0122103155290748240416050539
2025-02-01
2024-11-22

  • From This Site

    /content/journals/npj/10.2174/0122103155290748240416050539
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. StevensC.J. MurphyC. RobertsR. LucasL. SilvaF. FullerD.Q. Between china and south asia: A middle Asian corridor of crop dispersal and agricultural innovation in the bronze age.Holocene201626101541155510.1177/0959683616650268 27942165
     [Google Scholar]
  2. ZuardiA.W. History of cannabis as a medicine: A review.Rev. Bras. Psiquiatr.200628215315710.1590/S1516‑44462006000200015 16810401
     [Google Scholar]
  3. FarinonB. MolinariR. CostantiniL. MerendinoN. The seed of industrial hemp (Cannabis sativa L.): Nutritional quality and potential functionality for human health and nutrition.Nutrients2020127193510.3390/nu12071935 32610691
     [Google Scholar]
  4. HilligK.W. MahlbergP.G. A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae).Am. J. Bot.200491696697510.3732/ajb.91.6.966 21653452
     [Google Scholar]
  5. SchillingS. MelzerR. McCabeP.F. Cannabis sativa.Curr. Biol.2020301R8R910.1016/j.cub.2019.10.039 31910378
     [Google Scholar]
  6. PiluzzaG. DeloguG. CabrasA. MarcedduS. BullittaS. Differentiation between fiber and drug types of hemp (Cannabis sativa L.) from a collection of wild and domesticated accessions.Genet. Resour. Crop Evol.20136082331234210.1007/s10722‑013‑0001‑5
     [Google Scholar]
  7. PellatiF. BorgonettiV. BrighentiV. BiagiM. BenvenutiS. CorsiL. Cannabis sativa L. and nonpsychoactive cannabinoids: Their chemistry and role against oxidative stress, inflammation, and cancer.BioMed Res. Int.2018201811510.1155/2018/1691428 30627539
     [Google Scholar]
  8. SchlagA.K. O’SullivanS.E. ZafarR.R. NuttD.J. Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics.Neuropharmacology202119110858610.1016/j.neuropharm.2021.108586 33940011
     [Google Scholar]
  9. ZuardiA.W. CrippaJ.A. Fifty years of research on cannabidiol (cbd) as an anticonvulsant: The legacy of Brazilian groups.Br. J. Psychiatry2023456463464 38007685
     [Google Scholar]
  10. GabrilliM. An overview of medicinal Cannabis in Brazil.Available from: https://maragabrilli.com.br/wp-content/uploads/2019/11/Cannabis-Medicinal.pdf (Accessed on: January 20, 2023).
     [Google Scholar]
  11. de SouzaM.R. HenriquesA.T. LimbergerR.P. Medical cannabis regulation: An overview of models around the world with emphasis on the Brazilian scenario.J. Cannabis Res.2022413310.1186/s42238‑022‑00142‑z 35710586
     [Google Scholar]
  12. Leafly. Legal Cannabis now supports 428,059 american jobs.Available from: https://www.leafly.com/news/industry/cannabis-jobs-report (Accessed on: May 2, 2023).
  13. BDSA. State of Cannabis.Available from: https://bdsa.com/wp-content/uploads/2021/07/2021-State-of-Cannabis.pdf.2021 (Accessed on: May 20, 2022).
  14. Beaufour Ipsen Farmacêutica Ltda. Mevatil shbulashch.Available from: https://ipsen.com/websites/IPSENCOM-PROD/wp-content/uploads/sites/17/2019/04/04124129/Bula-do-Paciente-Mevatyl.pdf (Accessed on: April 19, 2023).
  15. G1 - Health. Medical cannabis: Imports grow 15 times in 5 years and pharmacies can sell 18 products; understand.Available from: https://g1.globo.com/saude/noticia/2022/06/05/cannabis-medicinal-importacao-cresce-15-vezes-em-5-anos-e-farmacias-podem-vender-18-produtos-entenda.ghtml (Accessed on: March 24, 2023).
  16. Anvisa. Anvisa optimizes the process of evaluating the import of Cannabis-derived products by individuals.Available from: https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2021/anvisa-otimiza-processo-de-avaliacao-da-importacao-de-produtos-derivados-de-cannabis-por-pessoa-fisica (Accessed on: February 19, 2023).
  17. So Mind. Medicinal Cannabis: The cannabis market for medicinal use in Brazil.Available from: https://kayamind.com/relatorio-cannabis-medicinal-no-brasil/ (Accessed on: February 19, 2023).
  18. So Mind. Hemp in Brazil. The possible economic and social impacts of a sustainable input in a country with great agricultural capacity. Available from: https://kayamind.com/relatorio-canhamo-no-brasil/ (Accessed on: February 19, 2023).
  19. MaL. PlatnickS. PlatnickH. Cannabidiol in treatment of autism spectrum disorder: A case study.Cureus2022148e2844210.7759/cureus.28442 36176817
     [Google Scholar]
  20. ErridgeS. GaffneyK.J. HolveyC. CoomberR. BarrosD.A.R. BhoskarU. MwimbaG. PraveenK. SymeonC. MohanS.S. SodergrenM.H. RuckerJ.J. Clinical outcome analysis of patients with autism spectrum disorder: Analysis from the uk medical cannabis registry.Ther. Adv. Psychopharmacol.2022122045125322111624010.1177/20451253221116240 36159065
     [Google Scholar]
  21. FreitasD.F. PimentaS. SoaresS. GonzagaD. MatosV.I. PriorC. The role of cannabinoids in neurodevelopmental disorders of children and adolescents.Rev. Neurol.202275718919710.33588/rn.7507.2022123 36169325
     [Google Scholar]
  22. HarrisM. ErridgeS. ErgisiM. NimalanD. KawkaM. SalazarO. AliR. LoupasakiK. HolveyC. CoomberR. UsmaniA. SajadM. HoareJ. RuckerJ.J. PlattM. SodergrenM.H. UK medical cannabis registry: An analysis of clinical outcomes of medicinal cannabis therapy for chronic pain conditions.Expert Rev. Clin. Pharmacol.202215447348510.1080/17512433.2022.2017771 34937477
     [Google Scholar]
  23. SilczukA. SmułekD. KołodziejM. GujskaJ. The construct of medical and non-medical marijuana - critical review.Int. J. Environ. Res. Public Health2022195276910.3390/ijerph19052769 35270462
     [Google Scholar]
  24. NewtonM. NewtonD.W. Cannabidiol or cbd oil: Help, hope, and hype for psychiatric and neurologic conditions.J. Am. Psychiatr. Nurses Assoc.202026544745710.1177/1078390320929410 32508204
     [Google Scholar]
  25. StarkT. MartinoD.S. DragoF. WotjakC.T. MicaleV. Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment.Pharmacol. Res.202117410593810.1016/j.phrs.2021.105938 34655773
     [Google Scholar]
  26. SarrisJ. SinclairJ. KaramacoskaD. DavidsonM. FirthJ. Medicinal cannabis for psychiatric disorders: A clinically-focused systematic review.BMC Psychiatry20202012410.1186/s12888‑019‑2409‑8 31948424
     [Google Scholar]
  27. CheungK.K.A. MitchellM.D. HeusslerH.S. Cannabidiol and neurodevelopmental disorders in children.Front. Psychiatry20211264344210.3389/fpsyt.2021.643442 34093265
     [Google Scholar]
  28. BatallaA. BosJ. PostmaA. BossongM.G. The impact of cannabidiol on human brain function: A systematic review.Front. Pharmacol.20211161818410.3389/fphar.2020.618184 33551817
     [Google Scholar]
  29. EfronD. FreemanJ.L. CranswickN. PayneJ.M. MulraneyM. PrakashC. LeeK.J. TaylorK. WilliamsK. A pilot randomised placebo‐controlled trial of cannabidiol to reduce severe behavioural problems in children and adolescents with intellectual disability.Br. J. Clin. Pharmacol.202187243644610.1111/bcp.14399 32478863
     [Google Scholar]
  30. CarliniE.A. The history of marijuana in Brazil.J. Bras. Psychiatrist.2006554314317 [Internet].10.1590/S0047‑20852006000400008
     [Google Scholar]
  31. Virtual health library. Resolution of the collegiate board - RDC no. 3, of January 26, 2015Available from: https://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2015/rdc0003_26_01_2015.pdf (Accessed on: May 28, 2023).
  32. Virtual health library. Resolution of the collegiate board - RDC No. 17, of May 6,2015Available from: https://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2015/rdc0017_06_05_2015.pdf (Accessed on: May 28, 2023).
  33. Anvisa. Resolution of the collegiate board - RDC No. 327, of December 9, 2019Available from: https://www.in.gov.br/en/web/dou/-/resolucao-da-diretoria-colegiada-rdc-n-327-de-9-de-dezembro-de-2019-232669072 (Accessed on: May 28, 2023).
  34. Anvisa. Technical and administrative requirements for the cultivation of the Cannabis spp. for medicinal and scientific purposes Public Consultation nº 655/ 2019Available from: https://static.poder360.com.br/2019/10/Anvisa-Cannabis-Apresentacao-Dicol-655-15out2019.pdf (Accessed on: May 28, 2023).
  35. Anvisa. Resolution of the collegiate board - RDC No 335, of January 24, 2020Available from: https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-335-de-24-de-janeiro-de-2020-239866072 (Accessed on: May 28, 2023).
  36. ] Virtual Health Library. Normative Instruction - IN No. 71, of September 12020Available from: https://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2020/IN_71_2020_.pdf (Accessed on: May 28, 2023).
  37. Anvisa. Resolution of the collegiate board - RDC No. 660, of March 30, 2022Available from: https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-660-de-30-de-marco-de-2022-389908959 (Accessed on: May 28, 2023).
  38. Public Ministry of the State of Paraná.The cultivation of Cannabis sativa for therapeutic medicinal purposes and the filing of preventive Habeas Corpus.Available from: https://site.mppr.mp.br/sites/hotsites/arquivos_restritos/files/migrados/ARTIGO_-_O_CULTIVO_DE_CANNABIS_SATIVA_PARA_FINS_MEDICINAIS_TERAPEUTICOS_E_A_IMPETRACAO_DE_HABEAS_CORPUS_PREVENTIVO_-_AGOSTO.pdf (Accessed on: May 28, 2023).
     [Google Scholar]
  39. Chamber of Deputies. Bill No. 399, of February 23, 2015Available from: https://www.camara.leg.br/proposicoesWeb/prop_mostrarintegra?codteor=1302175&filename=PL%20399/2015 (Accessed on: February 19, 2023).
  40. Virtual health library. Resolution of the Collegiate Board - RDC No. 26, of May 13, Available from: https://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2014/rdc0026_13_05_2014.pdf (Accessed on: May 5, 2023).
  41. Virtual health library. Resolution of the Collegiate Board - RDC No. 24, of June 14,Available from: https://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2011/rdc0024_14_06_2011.pdf (Accessed on: May 5, 2023).
  42. Ben-ShabatS. FrideE. SheskinT. TamiriT. RheeM.H. VogelZ. BisognoT. De PetrocellisL. Di MarzoV. MechoulamR. An entourage effect: Inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity.Eur. J. Pharmacol.19983531233110.1016/S0014‑2999(98)00392‑6 9721036
     [Google Scholar]
  43. PamplonaF.A. da SilvaL.R. CoanA.C. Potential clinical benefits of CBD-Rich Cannabis extracts over purified cbd in treatment-resistant epilepsy: Observational data meta-analysis.Front. Neurol.2018975910.3389/fneur.2018.00759 30258398
     [Google Scholar]
  44. RussoE.B. Taming THC: Potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects.Br. J. Pharmacol.201116371344136410.1111/j.1476‑5381.2011.01238.x 21749363
     [Google Scholar]
  45. U.S. Food and Drug Administration. Epidiolex [Bula].Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210365lbl.pdf (Accessed on: May 5, 2023).
  46. European Medicines Agency. Epidyolex.Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/epidyolex (Accessed on: May 5, 2023).
  47. U.S. Food and Drug Administration. Cesamet [Bula].Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/018677s011lbl.pdf (Accessed on: May 5, 2023).
  48. U.S. Food and Drug Administration. Marinol [Bula]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/018651s025s026lbl.pdf (Accessed on: May 5, 2023).
  49. U.S. Food and Drug Administration. Syndros [Pyla].Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205525s003lbl.pdf (Accessed on: May 5, 2023).
  50. Cannabis & Health Hemp Oil: what it is, types, benefits and how to use.Available from: https://www.cannabisesaude.com.br/hemp-oil/ (Accessed on: May 5, 2023).
  51. AndreC.M. HausmanJ.F. GuerrieroG. Cannabis sativa: The plant of the thousand and one molecules.Front. Plant Sci.201671910.3389/fpls.2016.00019 26870049
     [Google Scholar]
  52. ChandraS. LataH. ElSohlyM.A. WalkerL.A. PotterD. Cannabis cultivation: Methodological issues for obtaining medicalgrade product.Epilepsy Behav.,201770Pt B30231210.1016/j.yebeh.2016.11.029
     [Google Scholar]
  53. Embrace Hope.Available from: https://abraceesperanca.org.br (Accessed on: February 28, 2023).
  54. APEPI. Support for Medical Cannabis Research and Patients.Available from: https://www.apepi.org/ (Accessed on: February 28, 2023).
  55. Farmaindex. Mevatyl. Available from: https://farmaindex.com/mevatyl/21258 (Accessed on: April 19, 2023).
  56. CFM (Federal Council of Medicine). CFM Resolution No. 2,113, of October 30, 2014Available from: https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?jornal=1&pagina=183&data=16/12/2014 (Accessed on: April 19, 2023).
  57. MalíkM. VelechovskýJ. TlustošP. The overview of existing knowledge on medical cannabis plants growing.Plant Soil Environ.202167842544210.17221/96/2021‑PSE
     [Google Scholar]
  58. AliferisK.A. Bernard-PerronD. Cannabinomics: Application of metabolomics in Cannabis (Cannabis sativa L.) research and development.Front. Plant Sci.20201155410.3389/fpls.2020.00554 32457786
     [Google Scholar]
  59. CiesielskiW. DomagałaI. GarciaB. GirekT. OszczędaZ. SzczukaE. TomasikP. Specific way of controlling composition of cannabinoids and essential oil from Cannabis sativa var.Finola. Water202214568810.3390/w14050688
     [Google Scholar]
  60. PurdyS.J. HewavitharanaA.K. Azman HalimiR. MagnerN.J. PeterswaldT.J. TrebilcoA. KretzschmarT. HailstonesD. A One-Step grafting methodology can adjust stem morphology and increase thca yield in medicinal Cannabis.Agronomy 202212485210.3390/agronomy12040852
     [Google Scholar]
  61. Crispim MassuelaD. HartungJ. MunzS. ErpenbachF. Graeff-HönningerS. Impact of harvest time and pruning technique on total cbd concentration and yield of medicinal cannabis.Plants202211114010.3390/plants11010140 35009146
     [Google Scholar]
  62. CarvalhoV.M. de AlmeidaF.G. de Macêdo VieiraA.C. RochaE.D. CabralL.M. StronginR.M. Chemical profiling of Cannabis varieties cultivated for medical purposes in southeastern Brazil.Forensic Sci. Int.202233533511130910.1016/j.forsciint.2022.111309 35462181
     [Google Scholar]
  63. DanzigerN. BernsteinN. Too dense or not too dense: Higher planting density reduces cannabinoid uniformity but increases yield/area in drug-type medical Cannabis.Front. Plant Sci.20221371348110.3389/fpls.2022.713481 36247643
     [Google Scholar]
  64. Naim-FeilE. PembletonL.W. SpoonerL.E. MalthouseA.L. MinerA. QuinnM. PolotniankaR.M. BaillieR.C. SpangenbergG.C. CoganN.O.I. The characterization of key physiological traits of medicinal cannabis (Cannabis sativa L.) as a tool for precision breeding.BMC Plant Biol.202121129410.1186/s12870‑021‑03079‑2 34174826
     [Google Scholar]
  65. ADWA Cannabis MEDICINAL AND INDUSTRIAL CANNABIS IN BRAZIL: potential for cultivation.Available from: https://adwacannabis.com.br/sumario-executivo/ (Accessed on: February 19, 2023).
     [Google Scholar]
  66. SilvaA.G. BaldaçaraL.R. Official position of the Brazilian Psychiatric Association regarding the use of cannabis in psychiatric treatments.Debates in Psychiatry2022121610.25118/2763‑9037.2022.v12.393
     [Google Scholar]
/content/journals/npj/10.2174/0122103155290748240416050539
Loading
Factors for Implementing Medical Cannabis Cultivation in Brazil
Natural Products Journal, The 15, E250424229307 (2025); https://doi.org/10.2174/0122103155290748240416050539
/content/journals/npj/10.2174/0122103155290748240416050539
/content/journals/npj/10.2174/0122103155290748240416050539
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): cannabidiol; cultivation; legislation; Medical Cannabis; tetrahydrocannabinol; therapy

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test